International immunopharmacology.

ISSN 1567-5769Elsevier B.V.Netherlands
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Titles
International Immunopharmacology
Int. Immunopharmacol. (abbreviated)
International Immunopharmacology ELSEVIER
International immunopharmacology.
Int Immunopharmacol (abbreviated)
ISSN
1567-5769
1567-5769
eISSN
1878-1705
NLM ID
100965259
Publisher
Elsevier B.V.
Amsterdam ; New York : Elsevier Science, c2001-
Country
Language
ENG
English

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2001–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

MetricYearValueQuartileRankSource
JIF20254.7Q12261JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
1.354
Best Quartile
Q1
H-index
165
Subject categories (quartile varies by category)
  • Immunology and Allergy — Q1
  • Pharmacology — Q1
  • Immunology — Q2
More metrics
Coverage
2001–2026
Country
Netherlands
Region
Western Europe
Publisher
Elsevier B.V.
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
1859
Total documents (3 years)
4625
Total references
116039
Total citations (3 years)
26719
Citable documents (3 years)
4596
Citations per document (2 years)
5.64
References per document
62.42
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1878-1705, 1567-5769
SCImago Source ID
22432
SCImago Rank (across all SCImago source types)
2936

Publication activity

Publication activity
2025
1,859 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Allergy and Immunology; Cytokines; Immunity/drug effects; Immunotherapy; Pharmacology
Scopus:2001-2026
MEDLINE:MEDLINE: v1n1, Jan. 2001-; Index medicusIn: PubMed: v1n1, Jan. 2001-;
PubMed:MEDLINE: v1n1, Jan. 2001-; Index medicusIn: PubMed: v1n1, Jan. 2001-;